PGC1β activates an antiangiogenic program to repress neoangiogenesis in muscle ischemia.

scientific article published on 24 July 2014

PGC1β activates an antiangiogenic program to repress neoangiogenesis in muscle ischemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CELREP.2014.06.040
P698PubMed publication ID25066120
P5875ResearchGate publication ID264290478

P50authorAntonios MatsakasQ55856301
P2093author name stringVikas Yadav
Vihang A Narkar
Sabina Lorca
P433issue3
P921main subjectangiogenesis inhibitorQ574834
P304page(s)783-797
P577publication date2014-07-24
P1433published inCell ReportsQ5058165
P1476titlePGC1β activates an antiangiogenic program to repress neoangiogenesis in muscle ischemia
P478volume8

Reverse relations

cites work (P2860)
Q37139764Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature.
Q36933850Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice.
Q41579787Long-term PGC1β overexpression leads to apoptosis, autophagy and muscle wasting.
Q36231455Muscle Arnt/Hif1β Is Dispensable in Myofiber Type Determination, Vascularization and Insulin Sensitivity.
Q38719932Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
Q26770132The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology

Search more.